EPS Bio Technology Balance Sheet Health
Financial Health criteria checks 6/6
EPS Bio Technology has a total shareholder equity of NT$317.8M and total debt of NT$14.9M, which brings its debt-to-equity ratio to 4.7%. Its total assets and total liabilities are NT$530.0M and NT$212.2M respectively. EPS Bio Technology's EBIT is NT$27.5M making its interest coverage ratio -55.9. It has cash and short-term investments of NT$194.1M.
Key information
4.7%
Debt to equity ratio
NT$14.90m
Debt
| Interest coverage ratio | -55.9x |
| Cash | NT$194.13m |
| Equity | NT$317.83m |
| Total liabilities | NT$212.19m |
| Total assets | NT$530.01m |
Recent financial health updates
No updates
Recent updates
Should You Or Shouldn't You: A Dividend Analysis on EPS Bio Technology Corp. (GTSM:4183)
Apr 16
Will EPS Bio Technology (GTSM:4183) Multiply In Value Going Forward?
Mar 20Here's Why We Think EPS Bio Technology's (GTSM:4183) Statutory Earnings Might Be Conservative
Feb 22Do Fundamentals Have Any Role To Play In Driving EPS Bio Technology Corp.'s (GTSM:4183) Stock Up Recently?
Feb 01
Should EPS Bio Technology Corp. (GTSM:4183) Be Part Of Your Dividend Portfolio?
Jan 04Is EPS Bio Technology (GTSM:4183) Likely To Turn Things Around?
Dec 14We Think EPS Bio Technology's (GTSM:4183) Statutory Profit Might Understate Its Earnings Potential
Nov 23Financial Position Analysis
Short Term Liabilities: 4183's short term assets (NT$350.2M) exceed its short term liabilities (NT$101.1M).
Long Term Liabilities: 4183's short term assets (NT$350.2M) exceed its long term liabilities (NT$111.0M).
Debt to Equity History and Analysis
Debt Level: 4183 has more cash than its total debt.
Reducing Debt: 4183's debt to equity ratio has reduced from 9.2% to 4.7% over the past 5 years.
Debt Coverage: 4183's debt is well covered by operating cash flow (302.8%).
Interest Coverage: 4183 earns more interest than it pays, so coverage of interest payments is not a concern.